Clinical Trial Update: Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adebrelimab in combination with liposomal irinotecan, oxaliplatin, and 5-FU/leucovorin conversion therapy for locally advanced pancreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-FU/leucovorin (5-fluorouracil/leucovorin)
• Adebrelimab (adebrelimab)
• Irinotecan liposomal (II) (liposomal irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING